IF WE predict clinical outcome before clinical trials, can we speed up time to patient for a new drug?
3DEXPERIENCE Lab
IF WE revolutionize structural heart interventions, can we improve clinical outcome and accelerate time to market?

Structural heart interventions remain highly complex, with outcomes often depending on how devices interact with each patient’s unique anatomy. Traditional approaches rely on basic anatomical measurements, which are insufficient to predict device behavior and patient response. This creates challenges for both manufacturers, who face long development timelines, and physicians, who need better tools to optimize treatment decisions and improve outcomes.

FEops is redefining structural heart interventions with cutting-edge technology that transforms cardiac images into digital twins—virtual copies of the heart or its substructures. This approach enables highly personalized treatment planning, helping physicians and MedTech companies alike make better decisions, reduce risks, and accelerate innovation.
At the core is the CE-marked FEops HEARTguide™, a unique, cloud-based platform that goes beyond traditional anatomical measurement. By combining digital twins with AI-enabled anatomical analysis, HEARTguide™ delivers data-driven insights that improve procedure planning, efficiency, and outcomes.
Key Innovations
Pipeline Developments

By advancing the United Nations Sustainable Development Goal 3: Good Health and Well-Being, FEops contributes to healthier lives and improved care for patients of all ages. Its cloud-based platform, FEops HEARTguide™, leverages predictive simulation to give clinicians and medical device manufacturers unprecedented preoperative insights into how transcatheter structural heart devices will interact with a patient’s unique anatomy. This innovation supports safer procedures, more effective treatments, and better patient outcomes.

The 3DEXPERIENCE platform provides FEops with the tools needed to scale and optimize its solution. Its on-demand, cloud-based software and hardware ensure seamless and efficient delivery of FEops HEARTguide™ to clinicians worldwide. Advanced 3D multiphysics simulation enables the most accurate and personalized predictive insights into patient-specific device–heart interactions. In addition, the platform offers the potential to integrate data science and machine learning into FEops HEARTguide™ workflows, significantly reducing turnaround times and enhancing overall efficiency.

FEops is a medtech company advancing personalized care in structural heart disease through predictive simulations. Its cloud-based platform, FEops HEARTguide™, helps clinicians and device manufacturers optimize treatment planning, improve patient outcomes, and accelerate innovation.
Interested? Take your chance to elevate your project to the next level.